ICD-11 MMS

02 Neoplasms

Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues  (2B50-2E2Z)

Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues  (2B50-2D3Z)

Malignant neoplasms of male genital organs  (2C80-2C8Z)

2C82 Malignant neoplasms of prostate

2C82.0 Adenocarcinoma of prostate

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01


An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumours afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.

postcoordination

Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.

Histopathology  - only one may be selected
Has manifestation  - multiple selections are allowed
Has severity  - only one may be selected
Has alternative severity1  - only one may be selected
Has alternative severity2  - only one may be selected

synonyms

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.